[8-K] CLOROX CO /DE/ Reports Material Event
The Clorox Company announced executive leadership changes. Eric Reynolds, Executive Vice President – Chief Operating and Strategy Officer, provided notice of his intention to resign after 27 years with the company. He will step down from his role effective December 2, 2025.
Reynolds will be available on an advisory basis as needed through February 2, 2026. The company stated it does not expect to appoint a replacement for Mr. Reynolds.
- None.
- None.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer |
| incorporation) | Identification No.) |
(Address of principal executive offices) (Zip code)
(
(Registrant's telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) |
Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
1
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(b) On October 27, 2025, Eric Reynolds, Executive Vice President – Chief Operating and Strategy Officer of The Clorox Company (the “Company”), provided notice of his intention to resign from the Company, following 27 years of service. He will step down from his role effective December 2, 2025, and will be available on an advisory basis as needed through February 2, 2026. The Company does not expect to appoint a replacement for Mr. Reynolds.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| THE CLOROX COMPANY | ||
| Date: October 30, 2025 | By: | /s/ Angela Hilt |
| Angela Hilt | ||
| Executive Vice President – Chief Legal and External Affairs Officer and Corporate Secretary | ||
3
FAQ
What did Clorox (CLX) announce in this 8-K?
When will Eric Reynolds step down from his role at Clorox (CLX)?
How long will Eric Reynolds remain in an advisory capacity at Clorox (CLX)?
Will Clorox (CLX) appoint a replacement for Eric Reynolds?
What is Eric Reynolds’ role at Clorox (CLX)?
How long has Eric Reynolds served at Clorox (CLX)?
